The CureTalk Weekly Round Up: Interviews, Multiple Myeloma Research, Carfilzomib, and FDA

Health July 23, 2012 0 Comment

The CureTalk Weekly Round Up: Interviews, Multiple Myeloma Research, Carfilzomib, and FDA

FDA has approved Kyprolis and it is the first drug approval since 2006 for multiple myeloma. Reason to celebrate, indeed! Incidentally, we are also following multiple myeloma on CureTalk and we have plenty of myeloma research and news for our readers.

Dr. Ravi Vij

The highlight of this week has been our interview with myeloma expert Dr. Ravi Vij. Read his interview here to know about myeloma treatments currently under development.

Dr. Bikul Das in his lab.

We also connected with Dr. Bikul Das, and talked about his study on stem cells and altruism.

CureTalk buzzz…

Three dimensional image of the common cold virus. Image: University of Melbourne

CoMMpass trial with MMRF and US Oncology Research
IL-16 for multiple myeloma treatment
Cold virus simulation

Elotuzumab is onto phase III trials for safety and efficacy in combination with lenalidomide and dexamethasone.

FDA approves HIV drug, Truvada
Elotuzumab clinical trial results
Antibody drug conjugate for multiple myeloma

Jennifer Myers

Jennifer Myers, writes about mentally ill being considered dangerous.

Read Pat Killingswort’s blogs on Carfilzomib approval, here and here.

TrialX, our main site has a new look. Take a peek here.

Stay tuned for more…

Health, Myeloma Talk, TrialX

About the Author

Priya Menon

Priya is Scientific Media Editor at Applied Informatics/TrialX. She hosts and manages CureTalks, an internet radio talk show on healthcare which brings together experts and people on the same platform engaging in ‘Discussions for Solutions’. She holds masters in Microbiology, degrees in Patent Law, Media Law, and certifications in Writing in Sciences from Stanford University and HR Management from IIM Bangalore, India. She has extensive writing experience with a focus on cancer research, nutrition, and alternative therapies and presents a varied view on healthcare and associated domains. She is also a guest columnist at The Week. Follow (@Cure_talk).

Number of posts published: 644